Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:16 PM
Ignite Modification Date:
2025-12-24 @ 9:16 PM
NCT ID:
NCT05064904
Eligibility Criteria:
Inclusion Criteria:
1. Age ≥ 20 years old on the day of index discharge
2. AKI develops during admission, as defined with KDIGO-AKI Guideline, namely, elevation of serum creatinine above 0.3mg/dL within two days, above 1.5 times baseline and ever receives dialysis during this index hospitalization.
3. Patients who has KDIGO-AKI stage 2, 3 or who could wean from dialysis requiring AKI-D in the index hospitalization.
Exclusion Criteria:
1. Baseline estimated glomerular filtration rates (eGFR) less than 5ml/min/1.73m2 or greater than 90ml/min/1.73m2 according to MDRD equation after index discharge.
2. Patients receive further re-dialysis within 90 days after index hospital discharge, who are withdrawal for AKI-D. (sensors)
3. Previous gastrointestinal operations.
4. Patients with major hemorrhage, as defined with acute hemorrhage and requirement of blood transfusion during index admission.
5. Patients with a chronic lung disease requiring non-invasive or invasive positive pressure ventilation.
6. Solid organ or hematological transplantation donors.
7. Evidence of obstructive acute kidney injury.
8. Systolic blood pressure \< 110mmHg.
9. Pregnant women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT05064904
Study Brief:
Protocol Section:
NCT05064904